Horizon Kinetics Asset Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.7K | Sell |
11,034
-483
| -4% | -$599 | ﹤0.01% | 347 |
|
|
2025
Q1 | $13.6K | Hold |
11,517
| – | – | ﹤0.01% | 339 |
|
|
2024
Q4 | $21.1K | Buy |
11,517
+483
| +4% | +$884 | ﹤0.01% | 342 |
|
|
2024
Q3 | $18.8K | Sell |
11,034
-483
| -4% | -$821 | ﹤0.01% | 340 |
|
|
2024
Q2 | $15.8K | Hold |
11,517
| – | – | ﹤0.01% | 319 |
|
|
2024
Q1 | $43.2K | Hold |
11,517
| – | – | ﹤0.01% | 313 |
|
|
2023
Q4 | $113K | Sell |
11,517
-483
| -4% | -$4.74K | ﹤0.01% | 301 |
|
|
2023
Q3 | $100K | Hold |
12,000
| – | – | ﹤0.01% | 308 |
|
|
2023
Q2 | $160K | Hold |
12,000
| – | – | ﹤0.01% | 296 |
|
|
2023
Q1 | $139K | Hold |
12,000
| – | – | ﹤0.01% | 302 |
|
|
2022
Q4 | $98.2K | Hold |
12,000
| – | – | ﹤0.01% | 302 |
|
|
2022
Q3 | $70K | Hold |
12,000
| – | – | ﹤0.01% | 317 |
|
|
2022
Q2 | $53K | Hold |
12,000
| – | – | ﹤0.01% | 321 |
|
|
2022
Q1 | $109K | Hold |
12,000
| – | – | ﹤0.01% | 332 |
|
|
2021
Q4 | $246K | Hold |
12,000
| – | – | 0.01% | 306 |
|
|
2021
Q3 | $307K | Hold |
12,000
| – | – | 0.01% | 279 |
|
|
2021
Q2 | $420K | Hold |
12,000
| – | – | 0.01% | 255 |
|
|
2021
Q1 | $400K | Hold |
12,000
| – | – | 0.01% | 251 |
|
|
2020
Q4 | $311K | Hold |
12,000
| – | – | 0.01% | 282 |
|
|
2020
Q3 | $118K | Hold |
12,000
| – | – | ﹤0.01% | 349 |
|
|
2020
Q2 | $41K | Hold |
12,000
| – | – | ﹤0.01% | 396 |
|
|
2020
Q1 | $37K | Hold |
12,000
| – | – | ﹤0.01% | 373 |
|
|
2019
Q4 | $62K | Hold |
12,000
| – | – | ﹤0.01% | 468 |
|
|
2019
Q3 | $62K | Hold |
12,000
| – | – | ﹤0.01% | 469 |
|
|
2019
Q2 | $73K | Hold |
12,000
| – | – | ﹤0.01% | 478 |
|
|
2019
Q1 | $87K | Buy |
+12,000
| New | +$87K | ﹤0.01% | 472 |
|